Agenus Dividends Paid vs Cash And Cash Equivalents Changes Analysis

AGEN Stock

USD 3.51 0.01 0.29%

Agenus financial indicator trend analysis is way more than just evaluating Agenus Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Agenus Inc is a good investment. Please check the relationship between Agenus Dividends Paid and its Cash And Cash Equivalents Changes accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Dividends Paid vs Cash And Cash Equivalents Changes

Dividends Paid vs Cash And Cash Equivalents Changes Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Agenus Inc Dividends Paid account and Cash And Cash Equivalents Changes. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Agenus' Dividends Paid and Cash And Cash Equivalents Changes is -0.25. Overlapping area represents the amount of variation of Dividends Paid that can explain the historical movement of Cash And Cash Equivalents Changes in the same time period over historical financial statements of Agenus Inc, assuming nothing else is changed. The correlation between historical values of Agenus' Dividends Paid and Cash And Cash Equivalents Changes is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Dividends Paid of Agenus Inc are associated (or correlated) with its Cash And Cash Equivalents Changes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Cash Equivalents Changes has no effect on the direction of Dividends Paid i.e., Agenus' Dividends Paid and Cash And Cash Equivalents Changes go up and down completely randomly.

Correlation Coefficient

-0.25

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Cash And Cash Equivalents Changes

Most indicators from Agenus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Agenus Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

As of the 16th of February 2025, Selling General Administrative is likely to grow to about 95.1 M, while Issuance Of Capital Stock is likely to drop about 136.4 M.

Agenus fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets	Long Term Debt
Total Assets		0.59	0.74	0.83	-0.21	0.85	0.17	-0.83	0.8	0.79	0.89	0.85	0.8	-0.22	0.85	0.78	0.66	0.76	0.87	0.85	0.85	0.52	-0.21	0.75	0.23	-0.11
Short Long Term Debt Total	0.59		0.05	0.83	-0.37	0.82	0.89	-0.66	0.88	0.06	0.83	0.39	0.06	-0.18	0.85	0.39	0.93	0.79	0.66	0.82	0.14	0.96	-0.17	0.45	-0.08	0.06
Other Current Liab	0.74	0.05		0.54	-0.41	0.52	-0.28	-0.72	0.42	0.71	0.57	0.7	0.72	-0.24	0.52	0.85	0.18	0.5	0.74	0.5	0.76	0.01	-0.24	0.77	0.44	-0.22
Total Current Liabilities	0.83	0.83	0.54		-0.57	0.97	0.6	-0.9	0.98	0.33	0.97	0.69	0.35	-0.21	0.99	0.73	0.92	0.91	0.93	0.96	0.44	0.84	-0.2	0.84	0.22	-0.3
Total Stockholder Equity	-0.21	-0.37	-0.41	-0.57		-0.43	-0.44	0.65	-0.47	0.21	-0.46	-0.15	0.21	0.32	-0.51	-0.68	-0.42	-0.64	-0.67	-0.37	0.11	-0.42	0.31	-0.72	-0.27	0.22
Property Plant And Equipment Net	0.85	0.82	0.52	0.97	-0.43		0.58	-0.86	0.98	0.36	0.98	0.68	0.38	-0.16	0.98	0.65	0.91	0.86	0.87	1.0	0.45	0.82	-0.15	0.75	0.17	-0.29
Net Debt	0.17	0.89	-0.28	0.6	-0.44	0.58		-0.4	0.67	-0.41	0.56	0.01	-0.41	-0.11	0.61	0.1	0.8	0.59	0.38	0.57	-0.33	0.9	-0.1	0.21	-0.19	0.04
Retained Earnings	-0.83	-0.66	-0.72	-0.9	0.65	-0.86	-0.4		-0.85	-0.43	-0.9	-0.73	-0.44	0.49	-0.9	-0.87	-0.72	-0.94	-0.95	-0.84	-0.53	-0.63	0.49	-0.88	-0.23	0.18
Accounts Payable	0.8	0.88	0.42	0.98	-0.47	0.98	0.67	-0.85		0.28	0.97	0.65	0.29	-0.17	0.99	0.62	0.96	0.88	0.86	0.98	0.38	0.9	-0.16	0.76	0.13	-0.3
Cash	0.79	0.06	0.71	0.33	0.21	0.36	-0.41	-0.43	0.28		0.42	0.75	1.0	-0.12	0.36	0.55	0.1	0.28	0.47	0.38	0.99	-0.05	-0.12	0.42	0.24	0.05
Non Current Assets Total	0.89	0.83	0.57	0.97	-0.46	0.98	0.56	-0.9	0.97	0.42		0.69	0.43	-0.23	0.99	0.73	0.88	0.9	0.92	0.97	0.51	0.8	-0.22	0.78	0.14	-0.17
Non Currrent Assets Other	0.85	0.39	0.7	0.69	-0.15	0.68	0.01	-0.73	0.65	0.75	0.69		0.76	-0.23	0.69	0.61	0.53	0.59	0.7	0.7	0.8	0.39	-0.22	0.68	0.38	-0.3
Cash And Short Term Investments	0.8	0.06	0.72	0.35	0.21	0.38	-0.41	-0.44	0.29	1.0	0.43	0.76		-0.12	0.37	0.55	0.12	0.29	0.48	0.4	0.99	-0.04	-0.12	0.43	0.23	0.03
Common Stock Total Equity	-0.22	-0.18	-0.24	-0.21	0.32	-0.16	-0.11	0.49	-0.17	-0.12	-0.23	-0.23	-0.12		-0.24	-0.38	-0.08	-0.55	-0.32	-0.15	-0.15	-0.1	1.0	-0.26	0.12	-0.21
Common Stock Shares Outstanding	0.85	0.85	0.52	0.99	-0.51	0.98	0.61	-0.9	0.99	0.36	0.99	0.69	0.37	-0.24		0.71	0.93	0.92	0.92	0.97	0.46	0.85	-0.24	0.81	0.18	-0.26
Non Current Liabilities Total	0.78	0.39	0.85	0.73	-0.68	0.65	0.1	-0.87	0.62	0.55	0.73	0.61	0.55	-0.38	0.71		0.45	0.79	0.93	0.61	0.63	0.33	-0.38	0.9	0.35	-0.07
Other Current Assets	0.66	0.93	0.18	0.92	-0.42	0.91	0.8	-0.72	0.96	0.1	0.88	0.53	0.12	-0.08	0.93	0.45		0.81	0.74	0.91	0.2	0.98	-0.07	0.63	0.09	-0.29
Other Stockholder Equity	0.76	0.79	0.5	0.91	-0.64	0.86	0.59	-0.94	0.88	0.28	0.9	0.59	0.29	-0.55	0.92	0.79	0.81		0.91	0.84	0.38	0.76	-0.55	0.8	0.15	-0.1
Total Liab	0.87	0.66	0.74	0.93	-0.67	0.87	0.38	-0.95	0.86	0.47	0.92	0.7	0.48	-0.32	0.92	0.93	0.74	0.91		0.84	0.57	0.63	-0.31	0.93	0.3	-0.2
Property Plant And Equipment Gross	0.85	0.82	0.5	0.96	-0.37	1.0	0.57	-0.84	0.98	0.38	0.97	0.7	0.4	-0.15	0.97	0.61	0.91	0.84	0.84		0.47	0.83	-0.14	0.72	0.15	-0.3
Total Current Assets	0.85	0.14	0.76	0.44	0.11	0.45	-0.33	-0.53	0.38	0.99	0.51	0.8	0.99	-0.15	0.46	0.63	0.2	0.38	0.57	0.47		0.04	-0.15	0.51	0.23	0.02
Short Term Debt	0.52	0.96	0.01	0.84	-0.42	0.82	0.9	-0.63	0.9	-0.05	0.8	0.39	-0.04	-0.1	0.85	0.33	0.98	0.76	0.63	0.83	0.04		-0.09	0.5	-0.02	-0.2
Common Stock	-0.21	-0.17	-0.24	-0.2	0.31	-0.15	-0.1	0.49	-0.16	-0.12	-0.22	-0.22	-0.12	1.0	-0.24	-0.38	-0.07	-0.55	-0.31	-0.14	-0.15	-0.09		-0.26	0.13	-0.21
Other Liab	0.75	0.45	0.77	0.84	-0.72	0.75	0.21	-0.88	0.76	0.42	0.78	0.68	0.43	-0.26	0.81	0.9	0.63	0.8	0.93	0.72	0.51	0.5	-0.26		0.44	-0.47
Other Assets	0.23	-0.08	0.44	0.22	-0.27	0.17	-0.19	-0.23	0.13	0.24	0.14	0.38	0.23	0.12	0.18	0.35	0.09	0.15	0.3	0.15	0.23	-0.02	0.13	0.44		-0.43
Long Term Debt	-0.11	0.06	-0.22	-0.3	0.22	-0.29	0.04	0.18	-0.3	0.05	-0.17	-0.3	0.03	-0.21	-0.26	-0.07	-0.29	-0.1	-0.2	-0.3	0.02	-0.2	-0.21	-0.47	-0.43

Click cells to compare fundamentals

Agenus Account Relationship Matchups

Agenus fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	214.5M	466.0M	413.6M	313.9M	361.0M	379.0M
Short Long Term Debt Total	55.7M	58.3M	78.4M	350.2M	402.8M	422.9M
Other Current Liab	92.9M	110.7M	133.2M	48.7M	56.1M	28.4M
Total Current Liabilities	129.9M	156.9M	189.0M	255.9M	294.3M	309.0M
Total Stockholder Equity	(203.7M)	34.4M	(61.3M)	(160.3M)	(144.3M)	(137.1M)
Property Plant And Equipment Net	60.3M	91.1M	164.3M	163.0M	187.5M	196.9M
Net Debt	(44.1M)	(233.6M)	(100.2M)	274.1M	315.3M	331.0M
Retained Earnings	(1.5B)	(1.5B)	(1.7B)	(2.0B)	(1.8B)	(1.7B)
Accounts Payable	17.0M	30.5M	40.9M	61.4M	70.7M	74.2M
Cash	99.9M	291.9M	178.7M	76.1M	87.5M	71.1M
Non Current Assets Total	100.7M	134.0M	200.4M	201.5M	231.7M	243.3M
Non Currrent Assets Other	4.1M	9.5M	4.5M	5.7M	5.1M	3.5M
Cash And Short Term Investments	99.9M	306.9M	193.4M	76.1M	87.5M	81.2M
Common Stock Total Equity	1.4M	2.0M	2.6M	3.1M	2.8M	3.7M
Common Stock Shares Outstanding	8.6M	11.4M	14.1M	17.9M	20.6M	21.6M
Liabilities And Stockholders Equity	214.5M	466.0M	413.6M	313.9M	361.0M	379.0M
Non Current Liabilities Total	296.1M	261.1M	279.5M	206.4M	237.4M	249.2M
Other Current Assets	2.0M	3.2M	3.2M	10.5M	12.0M	12.6M
Other Stockholder Equity	1.2B	1.1B	1.2B	1.5B	1.7B	1.8B
Total Liab	426.0M	418.0M	468.5M	462.3M	531.6M	558.2M
Property Plant And Equipment Gross	60.3M	141.6M	218.4M	225.0M	258.7M	271.7M
Total Current Assets	113.8M	332.0M	213.1M	112.4M	129.3M	91.0M
Accumulated Other Comprehensive Income	2.8M	1.5M	915K	(955K)	(1.1M)	(1.2M)
Short Term Debt	2.8M	3.4M	2.5M	145.7M	167.5M	175.9M
Common Stock	2.0M	2.6M	3.1M	3.9M	3.5M	3.7M
Other Liab	216.1M	216.2M	205.9M	191.3M	220.0M	231.0M
Other Assets	1.4M	37.6M	9.5M	4.5M	4.0M	3.1M
Long Term Debt	18.9M	12.8M	12.6M	12.8M	14.7M	13.9M
Net Receivables	1.2M	1.5M	2.7M	25.8M	29.7M	31.2M
Good Will	25.5M	24.9M	25.5M	24.7M	22.3M	21.1M
Inventory	10.7M	20.4M	13.8M	1.0	1.15	1.09
Intangible Assets	10.9M	8.5M	6.2M	4.4M	5.1M	8.2M
Property Plant Equipment	26.3M	60.3M	91.1M	133.0M	153.0M	160.6M
Current Deferred Revenue	17.2M	12.4M	12.3M	18K	20.7K	19.7K
Net Tangible Assets	(21.0M)	(240.0M)	1.1M	159.2M	183.1M	192.3M
Noncontrolling Interest In Consolidated Entity	(6.0M)	(7.8M)	13.5M	6.4M	7.3M	7.7M
Retained Earnings Total Equity	(1.3B)	(1.5B)	(1.5B)	(1.7B)	(1.5B)	(1.6B)
Long Term Debt Total	13.4M	18.9M	12.8M	12.6M	11.3M	10.8M

When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:

How To Invest In Agenus

Details

Is Agenus Stock a good investment?

Details

What is Agenus' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.02)

Revenue Per Share

7.808

Quarterly Revenue Growth

0.033

Return On Assets

(0.22)

Return On Equity

(12.79)

The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Agenus Dividends Paid vs Cash And Cash Equivalents Changes Analysis

Dividends Paid vs Cash And Cash Equivalents Changes

Dividends Paid vs Cash And Cash Equivalents Changes Correlation Analysis

Correlation Coefficient

Dividends Paid

Cash And Cash Equivalents Changes

Agenus fundamental ratios Correlations

Agenus Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Agenus fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Common Stock Shares Outstanding	+ 0.99	Total Current Liabilities
Common Stock Shares Outstanding	+ 0.99	Accounts Payable
Total Current Assets	+ 0.99	Cash

Total Liab	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.9	Retained Earnings
Non Current Assets Total	- 0.9	Retained Earnings
Retained Earnings	- 0.9	Total Current Liabilities
Other Liab	- 0.88	Retained Earnings